How to buy Edwards Lifesciences Corporation (EW) shares in Australia

Learn how to easily invest in Edwards Lifesciences Corporation shares.

Edwards Lifesciences Corporation
+ $0.66 ( + 0.59%)

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Edwards Lifesciences Corporation (EW) is a leading medical devices business with stocks listed in the US. It opened the day at US$116.85 after a previous close of US$120.69. During the day the price has varied from a low of USD117.1 to a high of USD119.65. The latest price was USD119.42 (25 minute delay). Edwards Lifesciences Corporation is listed on the NYSE. All prices are listed in US Dollars.

How to buy shares in Edwards Lifesciences Corporation

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Edwards Lifesciences Corporation. Find the share by name or ticker symbol: EW. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Edwards Lifesciences Corporation reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$120.69, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Edwards Lifesciences Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Edwards Lifesciences Corporation. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Edwards Lifesciences Corporation stock price (NYSE:EW)

Use our graph to track the performance of EW stocks over time.

Edwards Lifesciences Corporation shares at a glance

Information last updated 2021-09-17.
Previous closeUS$120.69
Change US$-1.27
Change % -1.0523%
Volume 3,695,327
Information last updated 2021-10-09.
52-week rangeUS$70.92 - US$123.27
50-day moving average US$117.1803
200-day moving average US$103.37
Target priceUS$119.18
PE ratio 47.1918
Dividend yield N/A (0%)
Earnings per share (TTM) US$2.304

Where to buy Edwards Lifesciences Corporation stock

Name Product Standard brokerage for US shares Currency conversion fee Markets
eToro (global stocks)
50 pips (US$0.50 for every AU$100 exchanged)
Global shares, US shares, ETFs
Zero brokerage share trading on US, Hong Kong and European stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
50 pips (US$0.50 for every AU$100 exchanged)
ASX shares, US shares
Australia’s lowest-cost broker for ASX shares and ETFs.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
SelfWealth (Basic account)
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
Saxo Capital Markets (Classic account)
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Invest
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Edwards Lifesciences Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Edwards Lifesciences Corporation share growth calculator


Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.

Considering buying Edwards Lifesciences Corporation shares?

Before you consider Edwards Lifesciences Corporation, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.

Show me how

Edwards Lifesciences Corporation price performance over time

Historical closes compared with the last close of $119.42

1 week (2021-10-04) 12.27%
1 month (2021-09-15) -1.32%
3 months (2021-07-15) 12.30%
6 months (2021-04-15) 35.70%
1 year (2020-10-15) 39.97%
2 years (2019-10-15) 56.70%
3 years (2018-10-15) 152.67%
5 years (2016-10-14) 208.84%

Is Edwards Lifesciences Corporation under- or over-valued?

Valuing Edwards Lifesciences Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Edwards Lifesciences Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Edwards Lifesciences Corporation's P/E ratio

Edwards Lifesciences Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Edwards Lifesciences Corporation shares trade at around 47x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Edwards Lifesciences Corporation's PEG ratio

Edwards Lifesciences Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3545. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Edwards Lifesciences Corporation's EBITDA

Edwards Lifesciences Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$1.7 billion (£1.2 billion).

The EBITDA is a measure of a Edwards Lifesciences Corporation's overall financial performance and is widely used to measure a its profitability.

Edwards Lifesciences Corporation financials

Revenue TTM US$4.9 billion
Operating margin TTM 31.38%
Gross profit TTM US$3.3 billion
Return on assets TTM 13.71%
Return on equity TTM 32.6%
Profit margin 29.69%
Book value 8.238
Market capitalisation US$67.8 billion

TTM: trailing 12 months

Shorting Edwards Lifesciences Corporation shares

There are currently 5.9 million Edwards Lifesciences Corporation shares held short by investors – that's known as Edwards Lifesciences Corporation's "short interest". This figure is 1.3% down from 6.0 million last month.

There are a few different ways that this level of interest in shorting Edwards Lifesciences Corporation shares can be evaluated.

Edwards Lifesciences Corporation's "short interest ratio" (SIR)

Edwards Lifesciences Corporation's "short interest ratio" (SIR) is the quantity of Edwards Lifesciences Corporation shares currently shorted divided by the average quantity of Edwards Lifesciences Corporation shares traded daily (recently around 1.8 million). Edwards Lifesciences Corporation's SIR currently stands at 3.27. In other words for every 100,000 Edwards Lifesciences Corporation shares traded daily on the market, roughly 3270 shares are currently held short.

However Edwards Lifesciences Corporation's short interest can also be evaluated against the total number of Edwards Lifesciences Corporation shares, or, against the total number of tradable Edwards Lifesciences Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Edwards Lifesciences Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Edwards Lifesciences Corporation shares in existence, roughly 10 shares are currently held short) or 0.0096% of the tradable shares (for every 100,000 tradable Edwards Lifesciences Corporation shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Edwards Lifesciences Corporation.

Find out more about how you can short Edwards Lifesciences Corporation stock.

Edwards Lifesciences Corporation's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences Corporation.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Edwards Lifesciences Corporation's total ESG risk score

Total ESG risk: 21.68

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences Corporation's overall score of 21.68 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Edwards Lifesciences Corporation's environmental score

Environmental score: 4.78/100

Edwards Lifesciences Corporation's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Edwards Lifesciences Corporation's social score

Social score: 13.43/100

Edwards Lifesciences Corporation's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Edwards Lifesciences Corporation's governance score

Governance score: 10.96/100

Edwards Lifesciences Corporation's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Edwards Lifesciences Corporation's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Edwards Lifesciences Corporation scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences Corporation has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Edwards Lifesciences Corporation was last rated for ESG on: 2019-01-01.

Total ESG score 21.68
Total ESG percentile 24.1
Environmental score 4.78
Environmental score percentile 6
Social score 13.43
Social score percentile 6
Governance score 10.96
Governance score percentile 6
Level of controversy 2

Edwards Lifesciences Corporation share dividends

We're not expecting Edwards Lifesciences Corporation to pay a dividend over the next 12 months.

Have Edwards Lifesciences Corporation's shares ever split?

Edwards Lifesciences Corporation's shares were split on a 3:1 basis on 31 May 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences Corporation shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences Corporation shares which in turn could have impacted Edwards Lifesciences Corporation's share price.

Edwards Lifesciences Corporation share price volatility

Over the last 12 months, Edwards Lifesciences Corporation's shares have ranged in value from as little as US$70.92 up to US$123.27. A popular way to gauge a stock's volatility is its "beta".

EW.US volatility(beta: 1.08)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences Corporation's is 1.0751. This would suggest that Edwards Lifesciences Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Edwards Lifesciences Corporation overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site